LENSAR Inc reports results for the quarter ended in January 1 - Earnings Summary

• LENSAR Inc LNSR.OQ reported a quarterly adjusted loss of 13 cents​​ per share for the quarter ended January 1, higher than the same quarter last year, when the company reported EPS of -23 cents. The mean expectation of two analysts for the quarter was for a loss of 29 cents per share. Wall Street expected results to range from -33 cents to -26 cents per share.

• Revenue rose 38.2% to $13.54 million from a year ago; analysts expected $11.50 million.

• LENSAR Inc's reported EPS for the quarter was a loss of 13 cents​.

• The company reported a quarterly loss of $1.48 million.

• LENSAR Inc shares had risen by 27.9% this quarter and gained 67.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

Wall Street's median 12-month price target for LENSAR Inc is 11.00

This summary was machine generated from LSEG data November 7 at 08:44 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)